FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162289930> ?p ?o ?g. }

• W2162289930 abstract "Abstract Background Our previous studies have identified that miR-125b was overexpressed in type II endometrial carcinoma (EC) cells compared with type I using microRNAs microarray. Although recent studies have shown the important role of miR-125b in several tumors and overexpression of miR-125b in advanced EC, its function in this disease has not yet been defined. In the present study, we tried to confirm the result of microRNAs microarray and further investigated the functions of miR-125b in EC, and tried to find new downstream targets of miR-125b. Methods Differential expression of miR-125b was detected between type II EC cells (KLE, AN3CA) with ER negative and type I EC cells (ishikawa, RL95-2) with ER positive by qRT-PCR and northern blotting. The effects of miR-125b of on proliferation, migration, and target protein expression were evaluated by CCK8 assay, wound healing assay, transwell migration assay, western blotting, and Tumorigenicity assays in nude mice. In addition, luciferase reporter plasmid was constructed to demonstrate the direct target of miR-125b. Results MiR-125b was overexpressed in type II EC cells compared with type I. Exogenous miR-125b expression increased proliferation and migration of ishikawa cells and abrogating expression of miR-125b suppressed proliferation, and migration of AN3CA cells in vitro. In addition, in vivo tumor formation assay confirmed that forced miR-125b expression promoted proliferation potential of ishikawa cells, and tumor suppressor gene Tumor Protein 53-Induced Nuclear Protein 1 (TP53INP1) was identified to be the direct target of miR-125b. Conclusions TP53INP1 was newly identified to be the direct downstream target of miR-125b. MiR-125b, which was overexpressed in type II EC cells compared with type I, contributes to malignancy of type II EC possibly through down-regulating TP53INP1." @default.
• W2162289930 created "2016-06-24" @default.
• W2162289930 creator A5023282229 @default.
• W2162289930 creator A5036509922 @default.
• W2162289930 creator A5063991190 @default.
• W2162289930 creator A5065844265 @default.
• W2162289930 creator A5068612123 @default.
• W2162289930 creator A5074920934 @default.
• W2162289930 creator A5090366405 @default.
• W2162289930 date "2011-10-05" @default.
• W2162289930 modified "2023-09-27" @default.
• W2162289930 title "MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo" @default.
• W2162289930 cites W144423133 @default.
• W2162289930 cites W1965371218 @default.
• W2162289930 cites W1975167804 @default.
• W2162289930 cites W1978337436 @default.
• W2162289930 cites W1979490110 @default.
• W2162289930 cites W1988389975 @default.
• W2162289930 cites W1992523161 @default.
• W2162289930 cites W2002800994 @default.
• W2162289930 cites W2004503198 @default.
• W2162289930 cites W2028454636 @default.
• W2162289930 cites W2030888171 @default.
• W2162289930 cites W2044869180 @default.
• W2162289930 cites W2047213909 @default.
• W2162289930 cites W2047529648 @default.
• W2162289930 cites W2054109341 @default.
• W2162289930 cites W2054336427 @default.
• W2162289930 cites W2057486966 @default.
• W2162289930 cites W2058998656 @default.
• W2162289930 cites W2062378348 @default.
• W2162289930 cites W2069540657 @default.
• W2162289930 cites W2076287538 @default.
• W2162289930 cites W2079251691 @default.
• W2162289930 cites W2082568558 @default.
• W2162289930 cites W2082996759 @default.
• W2162289930 cites W2083381199 @default.
• W2162289930 cites W2084284022 @default.
• W2162289930 cites W2098733239 @default.
• W2162289930 cites W2109377963 @default.
• W2162289930 cites W2130979840 @default.
• W2162289930 cites W2138664009 @default.
• W2162289930 cites W2141316782 @default.
• W2162289930 cites W2150912425 @default.
• W2162289930 cites W2152558372 @default.
• W2162289930 cites W52806365 @default.
• W2162289930 doi "https://doi.org/10.1186/1471-2407-11-425" @default.
• W2162289930 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3210504" @default.
• W2162289930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21970405" @default.
• W2162289930 hasPublicationYear "2011" @default.
• W2162289930 type Work @default.
• W2162289930 sameAs 2162289930 @default.
• W2162289930 citedByCount "105" @default.
• W2162289930 countsByYear W21622899302012 @default.
• W2162289930 countsByYear W21622899302013 @default.
• W2162289930 countsByYear W21622899302014 @default.
• W2162289930 countsByYear W21622899302015 @default.
• W2162289930 countsByYear W21622899302016 @default.
• W2162289930 countsByYear W21622899302017 @default.
• W2162289930 countsByYear W21622899302018 @default.
• W2162289930 countsByYear W21622899302019 @default.
• W2162289930 countsByYear W21622899302020 @default.
• W2162289930 countsByYear W21622899302021 @default.
• W2162289930 countsByYear W21622899302022 @default.
• W2162289930 crossrefType "journal-article" @default.
• W2162289930 hasAuthorship W2162289930A5023282229 @default.
• W2162289930 hasAuthorship W2162289930A5036509922 @default.
• W2162289930 hasAuthorship W2162289930A5063991190 @default.
• W2162289930 hasAuthorship W2162289930A5065844265 @default.
• W2162289930 hasAuthorship W2162289930A5068612123 @default.
• W2162289930 hasAuthorship W2162289930A5074920934 @default.
• W2162289930 hasAuthorship W2162289930A5090366405 @default.
• W2162289930 hasBestOaLocation W21622899301 @default.
• W2162289930 hasConcept C104317684 @default.
• W2162289930 hasConcept C11957725 @default.
• W2162289930 hasConcept C121608353 @default.
• W2162289930 hasConcept C126322002 @default.
• W2162289930 hasConcept C145059251 @default.
• W2162289930 hasConcept C150194340 @default.
• W2162289930 hasConcept C150903083 @default.
• W2162289930 hasConcept C153911025 @default.
• W2162289930 hasConcept C161733203 @default.
• W2162289930 hasConcept C179185449 @default.
• W2162289930 hasConcept C185592680 @default.
• W2162289930 hasConcept C202751555 @default.
• W2162289930 hasConcept C207001950 @default.
• W2162289930 hasConcept C2776415932 @default.
• W2162289930 hasConcept C502942594 @default.
• W2162289930 hasConcept C55493867 @default.
• W2162289930 hasConcept C71924100 @default.
• W2162289930 hasConcept C8415881 @default.
• W2162289930 hasConcept C85265743 @default.
• W2162289930 hasConcept C86803240 @default.
• W2162289930 hasConceptScore W2162289930C104317684 @default.
• W2162289930 hasConceptScore W2162289930C11957725 @default.
• W2162289930 hasConceptScore W2162289930C121608353 @default.
• W2162289930 hasConceptScore W2162289930C126322002 @default.
• W2162289930 hasConceptScore W2162289930C145059251 @default.
• W2162289930 hasConceptScore W2162289930C150194340 @default.
• W2162289930 hasConceptScore W2162289930C150903083 @default.

• next